Cargando…
Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness
Skeletal muscle wasting in the intensive care unit (ICU) has been associated with mortality, but it is unclear whether sarcopenia, defined by skeletal muscle mass and function, is useful for detailed risk stratification after ICU discharge. In this cohort study, 72 critically ill patients with an IC...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401251/ https://www.ncbi.nlm.nih.gov/pubmed/34444886 http://dx.doi.org/10.3390/nu13082726 |
_version_ | 1783745506605793280 |
---|---|
author | Yanagi, Naoya Koike, Tomotaka Kamiya, Kentaro Hamazaki, Nobuaki Nozaki, Kohei Ichikawa, Takafumi Matsunaga, Atsuhiko Kuroiwa, Masayuki Arai, Masayasu |
author_facet | Yanagi, Naoya Koike, Tomotaka Kamiya, Kentaro Hamazaki, Nobuaki Nozaki, Kohei Ichikawa, Takafumi Matsunaga, Atsuhiko Kuroiwa, Masayuki Arai, Masayasu |
author_sort | Yanagi, Naoya |
collection | PubMed |
description | Skeletal muscle wasting in the intensive care unit (ICU) has been associated with mortality, but it is unclear whether sarcopenia, defined by skeletal muscle mass and function, is useful for detailed risk stratification after ICU discharge. In this cohort study, 72 critically ill patients with an ICU stay of ≥48 h were identified. Skeletal muscle mass was assessed from the muscle thickness (MT) of the patients’ quadriceps using ultrasound images before ICU discharge. Skeletal muscle function was assessed from the patients’ muscle strength (MS) before ICU discharge according to the Medical Research Council sum score. A diagnosis of sarcopenia in the ICU was made in patients with low MT and low MS. The study endpoint was 1-year mortality. Sarcopenia in the ICU was diagnosed in 26/72 patients (36%). After adjusting for covariates in the Cox regression, sarcopenia in the ICU was significantly associated with 1-year mortality (hazard ratio 3.82; 95% confidence interval, 1.40–10.42). Sarcopenia in the ICU, defined by low skeletal muscle mass and function, was associated with 1-year mortality in survivors of critical illness. Skeletal muscle mass and function assessed at the bedside could be used to identify higher-risk patients in the ICU. |
format | Online Article Text |
id | pubmed-8401251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84012512021-08-29 Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness Yanagi, Naoya Koike, Tomotaka Kamiya, Kentaro Hamazaki, Nobuaki Nozaki, Kohei Ichikawa, Takafumi Matsunaga, Atsuhiko Kuroiwa, Masayuki Arai, Masayasu Nutrients Article Skeletal muscle wasting in the intensive care unit (ICU) has been associated with mortality, but it is unclear whether sarcopenia, defined by skeletal muscle mass and function, is useful for detailed risk stratification after ICU discharge. In this cohort study, 72 critically ill patients with an ICU stay of ≥48 h were identified. Skeletal muscle mass was assessed from the muscle thickness (MT) of the patients’ quadriceps using ultrasound images before ICU discharge. Skeletal muscle function was assessed from the patients’ muscle strength (MS) before ICU discharge according to the Medical Research Council sum score. A diagnosis of sarcopenia in the ICU was made in patients with low MT and low MS. The study endpoint was 1-year mortality. Sarcopenia in the ICU was diagnosed in 26/72 patients (36%). After adjusting for covariates in the Cox regression, sarcopenia in the ICU was significantly associated with 1-year mortality (hazard ratio 3.82; 95% confidence interval, 1.40–10.42). Sarcopenia in the ICU, defined by low skeletal muscle mass and function, was associated with 1-year mortality in survivors of critical illness. Skeletal muscle mass and function assessed at the bedside could be used to identify higher-risk patients in the ICU. MDPI 2021-08-08 /pmc/articles/PMC8401251/ /pubmed/34444886 http://dx.doi.org/10.3390/nu13082726 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yanagi, Naoya Koike, Tomotaka Kamiya, Kentaro Hamazaki, Nobuaki Nozaki, Kohei Ichikawa, Takafumi Matsunaga, Atsuhiko Kuroiwa, Masayuki Arai, Masayasu Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness |
title | Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness |
title_full | Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness |
title_fullStr | Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness |
title_full_unstemmed | Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness |
title_short | Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness |
title_sort | assessment of sarcopenia in the intensive care unit and 1-year mortality in survivors of critical illness |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401251/ https://www.ncbi.nlm.nih.gov/pubmed/34444886 http://dx.doi.org/10.3390/nu13082726 |
work_keys_str_mv | AT yanaginaoya assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness AT koiketomotaka assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness AT kamiyakentaro assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness AT hamazakinobuaki assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness AT nozakikohei assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness AT ichikawatakafumi assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness AT matsunagaatsuhiko assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness AT kuroiwamasayuki assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness AT araimasayasu assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness |